ERIN MANN: Open Payments
NPI 1639711401 · MIDLAND, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$87 in 4 payments from 4 companies in 2025. Trend: 2023 $132 · 2024 $338 · 2025 $87
Food & beverage: $87
| Company | Payments | Amount |
|---|---|---|
| REVANCE THERAPEUTICS, INC. | 1 | $28 |
| Galderma Laboratories, L.P. | 1 | $21 |
| ABBVIE INC. | 1 | $21 |
| Novo Nordisk Inc | 1 | $17 |
Products named: DAXXIFY, QULIPTA, Saxenda.
Industry payments across TX — which companies pay providers there.
